Latest News about Biotech
Recent news which mentions Biotech
FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson/Atrophy Program
March 08, 2023
Tickers
IKT
From Benzinga
From Phil's Stock World
RenovoRx's Targeted Prostate Cancer Treatment Shows Positive Trend In Median Overall Survival Versus Standard Care
March 08, 2023
Tickers
RNXT
From Benzinga
OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck
March 08, 2023
From Benzinga
After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use
March 08, 2023
From Benzinga
Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids
March 08, 2023
Tickers
MESO
From Benzinga
From Benzinga
Fresh Tracks Therapeutics Evaluating Strategic Options To Further Develop Its Lead Product
March 08, 2023
Tickers
FRTX
From Benzinga
Tickers
INNO
From Business Journals
From Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success
March 07, 2023
From Benzinga
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
March 07, 2023
From Benzinga
The AZ Inno Madness bracket contest is back: Vote to pick who will advance in the first round
March 07, 2023
Tickers
INNO
From Business Journals
Adial Pharma Sees Clear, Cost-Effective Path Toward FDA Approval For Alcohol Use Disorder Candidate
March 07, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.